A personalized vaccine to treat glioblastoma is safe and may improve survival rates, according to a Phase 1 trial at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Personalized vaccine shows promise against aggressive brain cancer
Safe Safe with no serious side effects
5 Years One long-term survivor recurrence-free
WashU And Geneos Co-led by WashU and Geneos
Phase 1 phase
No Serious Side Effects safety